Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Mar;93(2):305-307.
doi: 10.1590/abd1806-4841.20187200.

Diphenciprone as a therapeutic alternative to exuberant periungual warts

Affiliations
Case Reports

Diphenciprone as a therapeutic alternative to exuberant periungual warts

Bruno de Castro E Souza et al. An Bras Dermatol. 2018 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interests: None.

Figures

Figure 1
Figure 1
Initial presentation with involvement of nine fingers
Figure 2
Figure 2
Left hand with significant improvement after treatment

References

    1. Ockenfels HM. Therapeutic management of cutaneous and genital warts. J Dtsch Dermatol Ges. 2016;14:892–899. - PubMed
    1. Word AP, Nezafati KA, Cruz PD Jr. Treatment of Warts With Contact Allergens. Dermatitis. 2015;26:32–37. - PubMed
    1. Suh DW, Lew BL, Sim WY. Investigations of the efficacy of diphenylcyclopropenone immunotherapy for the treatment of warts. Int J Dermatol. 2014;53:e567–e571. - PubMed
    1. Choi MH, Seo SH, Kim IH, Son SW. Comparative study on the sustained efficacy of diphencyprone immunotherapy versus cryotherapy in viral warts. Pediatr Dermatol. 2008;25:398–399. - PubMed
    1. Choi Y, Kim DH, Jin SY, Lee AY, Lee SH. Topical immunotherapy with diphenylcyclopropenone is effective and preferred in the treatment of periungual warts. Ann Dermatol. 2013;25:434–439. - PMC - PubMed

Publication types